This month’s Going on Trial newsletter explores how eye tracking might be used beyond helping with diagnosis, among other drug development news.

Autism researchers can’t agree on how far to go to validate the input they gather from minimally verbal autistic people who use certain communication devices.

A new individualized approach to transcranial magnetic stimulation may one day be an effective treatment for social and communication difficulties, if the results from Duan’s small preliminary trial pan out.

The new tool could help clinicians diagnose autism in children younger than 3, the findings show.

The discovery could help clinicians diagnose children who carry mutations in the gene, called SCN2A, and gauge their responses to potential therapies.

Intentional interactions with autistic people led Sasson to refocus his research.

In this edition, a strategy to help autistic children adapt their skills to new situations shows no benefit, but an early-life autism biomarker does.

The app relies on artificial intelligence and could help researchers standardize studies of pupil differences in autistic people and in mouse models of autism.

Integrating genetic analyses into studies of babies’ brain development could help us understand how autism-related genes contribute to autism traits.

How autistic people look at a face may be linked more to alexithymia, a condition marked by difficulties recognizing one’s own emotions, than to autism.